Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Cash from Financing Activities (2016 - 2025)

Ultralife has reported Cash from Financing Activities over the past 16 years, most recently at -$687000.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$687000.0 for Q4 2025, down 101.5% from a year ago — trailing twelve months through Dec 2025 was -$4.7 million (down 115.66% YoY), and the annual figure for FY2025 was -$4.7 million, down 115.66%.
  • Cash from Financing Activities for Q4 2025 was -$687000.0 at Ultralife, down from -$651000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ULBI hit a ceiling of $45.7 million in Q4 2024 and a floor of -$11.9 million in Q2 2024.
  • Median Cash from Financing Activities over the past 5 years was -$301000.0 (2023), compared with a mean of $3.0 million.
  • Peak annual rise in Cash from Financing Activities hit 15276.08% in 2024, while the deepest fall reached 863.64% in 2024.
  • Ultralife's Cash from Financing Activities stood at $20.6 million in 2021, then crashed by 94.06% to $1.2 million in 2022, then plummeted by 124.61% to -$301000.0 in 2023, then surged by 15276.08% to $45.7 million in 2024, then tumbled by 101.5% to -$687000.0 in 2025.
  • The last three reported values for Cash from Financing Activities were -$687000.0 (Q4 2025), -$651000.0 (Q3 2025), and -$2.7 million (Q2 2025) per Business Quant data.